rs35109010
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The ENST00000695826.1(CD55):c.1082-10090_1082-10088delATG variant causes a intron change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.49 ( 18396 hom., cov: 0)
Consequence
CD55
ENST00000695826.1 intron
ENST00000695826.1 intron
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.788
Publications
0 publications found
Genes affected
CD55 (HGNC:2665): (CD55 molecule (Cromer blood group)) This gene encodes a glycoprotein involved in the regulation of the complement cascade. Binding of the encoded protein to complement proteins accelerates their decay, thereby disrupting the cascade and preventing damage to host cells. Antigens present on this protein constitute the Cromer blood group system (CROM). Alternative splicing results in multiple transcript variants. The predominant transcript variant encodes a membrane-bound protein, but alternatively spliced transcripts may produce soluble proteins. [provided by RefSeq, Jul 2014]
CD55 Gene-Disease associations (from GenCC):
- protein-losing enteropathyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.529 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CD55 | ENST00000695826.1 | c.1082-10090_1082-10088delATG | intron_variant | Intron 9 of 9 | ENSP00000512203.1 | |||||
| CD55 | ENST00000618707.2 | c.584-4691_584-4689delATG | intron_variant | Intron 6 of 7 | 6 | ENSP00000495477.1 | ||||
| CD55 | ENST00000634386.1 | n.167-22543_167-22541delATG | intron_variant | Intron 3 of 4 | 5 | ENSP00000493859.1 |
Frequencies
GnomAD3 genomes AF: 0.489 AC: 74102AN: 151524Hom.: 18388 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
74102
AN:
151524
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.489 AC: 74126AN: 151642Hom.: 18396 Cov.: 0 AF XY: 0.491 AC XY: 36319AN XY: 74036 show subpopulations
GnomAD4 genome
AF:
AC:
74126
AN:
151642
Hom.:
Cov.:
0
AF XY:
AC XY:
36319
AN XY:
74036
show subpopulations
African (AFR)
AF:
AC:
17068
AN:
41342
American (AMR)
AF:
AC:
7574
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
AC:
1611
AN:
3466
East Asian (EAS)
AF:
AC:
2127
AN:
5152
South Asian (SAS)
AF:
AC:
2561
AN:
4802
European-Finnish (FIN)
AF:
AC:
5486
AN:
10454
Middle Eastern (MID)
AF:
AC:
120
AN:
294
European-Non Finnish (NFE)
AF:
AC:
36183
AN:
67868
Other (OTH)
AF:
AC:
966
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1912
3824
5737
7649
9561
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
670
1340
2010
2680
3350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1654
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.